Basics |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
|
IPO Date: |
January 2, 1990 |
Sector: |
Healthcare |
Industry: |
Life Sciences Tools and Services |
Market Cap: |
$186.01B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$2.01 | 0.99%
|
Avg Daily Range (30 D): |
$5.07 | 1.06%
|
Avg Daily Range (90 D): |
$5.52 | 1.28%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.84M |
Avg Daily Volume (30 D): |
1.82M |
Avg Daily Volume (90 D): |
2.18M |
Trade Size |
Avg Trade Size (Sh.): |
96 |
Avg Trade Size (Sh.) (30 D): |
37 |
Avg Trade Size (Sh.) (90 D): |
38 |
Institutional Trades |
Total Inst.Trades: |
37,431 |
Avg Inst. Trade: |
$10.93M |
Avg Inst. Trade (30 D): |
$32.11M |
Avg Inst. Trade (90 D): |
$30.47M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
6 |
Market Closing Trades |
Avg Closing Trade: |
$51.16M |
Avg Closing Trade (30 D): |
$128.39M |
Avg Closing Trade (90 D): |
$134.77M |
Avg Closing Volume: |
164.92K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$17.32
|
$4.28
|
$3.99
|
Diluted EPS
|
$17.29
|
$4.28
|
$3.98
|
Revenue
|
$ 43.21B
|
$ 10.86B
|
$ 10.36B
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ 6.58B
|
$ 1.62B
|
$ 1.51B
|
Operating Income / Loss
|
$ 7.4B
|
$ 1.83B
|
$ 1.72B
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -2744M
|
$ 120M
|
$ 94M
|
PE Ratio
|
28.17
|
|
|
|
|
|